BWV Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 gruod. 2023 @ 22:59):

Stats
Dzisiejszy wolumen	520 290
Średni wolumen	435 531
Kapitalizacja rynkowa	3.41M
EPS	$0 ( 2024-03-14 )
Następna data zysków	( $0 ) 2024-05-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.167
ATR14	$0.0440 (25.36%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-15	Schiess Ralph	Sell	0	Common Stock
2023-12-15	Bruhlmann Christian	Sell	0	Common Stock
2023-10-04	Campbell Neil J	Sell	532 326	Stock Option
2023-10-04	Harmon Bruce	Sell	177 442	Stock Option
2023-05-31	Jeremic Vuk	Buy	6 360	Common Stock

INSIDER POWER
-71.65
Last 40 transactions
Buy: 4 886 577 \| Sell: 8 258 116

Wolumen Korelacja

Długi: -0.25 (neutral)

Krótki: -0.68 (moderate negative)

Signal:(32.398) Neutral

iPath Goldman Sachs Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

iPath Goldman Sachs Korelacja - Waluta/Towar

-0.63
( weak negative )

-0.65
( moderate negative )

0.00
( neutral )

-0.78
( moderate negative )

-0.25
( neutral )

0.40
( neutral )

iPath Goldman Sachs Finanse

Annual	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-1.080

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-1.080

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.309

FY	2020
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.195

Financial Reports:

No articles found.

iPath Goldman Sachs

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.

Aktualne aktualizacje dla iPath Goldman Sachs [BWV]

Upcoming Earnings Alert